RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan AC Sterne 
;
Jelena Savović;
Matthew J Page;
Roy G Elbers;
Natalie S Blencowe;
Isabelle Boutron;
Christopher J Cates;
Hung-Yuan Cheng;
Mark S Corbett;
Sandra M Eldridge;
+18 more...
Jonathan R Emberson;
Miguel A Hernán;
Sally Hopewell;
Asbjørn Hróbjartsson;
Daniela R Junqueira;
Peter Jüni;
Jamie J Kirkham;
Toby Lasserson;
Tianjing Li;
Alexandra McAleenan;
Barnaby C Reeves;
Sasha Shepperd ;
Ian Shrier;
Lesley A Stewart;
Kate Tilling;
Ian R White;
Penny F Whiting;
Julian PT Higgins;
(2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials.
BMJ (Clinical research ed.), 366.
l4898-.
ISSN 0959-8138
DOI: 10.1136/bmj.l4898
;
Jelena Savović;
Matthew J Page;
Roy G Elbers;
Natalie S Blencowe;
Isabelle Boutron;
Christopher J Cates;
Hung-Yuan Cheng;
Mark S Corbett;
Sandra M Eldridge;
+18 more...
Jonathan R Emberson;
Miguel A Hernán;
Sally Hopewell;
Asbjørn Hróbjartsson;
Daniela R Junqueira;
Peter Jüni;
Jamie J Kirkham;
Toby Lasserson;
Tianjing Li;
Alexandra McAleenan;
Barnaby C Reeves;
Sasha Shepperd ;
Ian Shrier;
Lesley A Stewart;
Kate Tilling;
Ian R White;
Penny F Whiting;
Julian PT Higgins;
(2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials.
BMJ (Clinical research ed.), 366.
l4898-.
ISSN 0959-8138
DOI: 10.1136/bmj.l4898
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
-
picture_as_pdf - Sterne_etal_2019_RoB_2.pdf
-
subject - Accepted Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads